FDA Clears Life-Saving Drug for Over-the-Counter Sales – Rolling Stone – Jan. 18, 2019

The Food and Drug Administration (FDA) announced it was taking unprecedented steps to encourage drug companies to develop over-the-counter (OTC) versions of the overdose antidote naloxone in an effort to increase access and cut costs for consumers in hopes of reducing opioid deaths. Read More.